Zan N, Li J, Yao J, Wu S, Li J, Chen F
Nat Commun. 2025; 16(1):2034.
PMID: 40016246
PMC: 11868578.
DOI: 10.1038/s41467-025-57281-z.
Wang L, Wang Y, Ke Z, Wang Z, Guo Y, Zhang Y
Front Immunol. 2024; 15:1444253.
PMID: 39391315
PMC: 11464301.
DOI: 10.3389/fimmu.2024.1444253.
Luo Y, Zhou J, Ji H, Xu D, Zheng A, Wang X
Nat Commun. 2024; 15(1):6964.
PMID: 39138195
PMC: 11322655.
DOI: 10.1038/s41467-024-51192-1.
Ruan K, Bai G, Fang Y, Li D, Li T, Liu X
Sci China Life Sci. 2024; 67(9):1792-1832.
PMID: 39037698
DOI: 10.1007/s11427-024-2661-3.
Mendoza-Ramirez N, Garcia-Cordero J, Shrivastava G, Cedillo-Barron L
J Immunol Res. 2024; 2024:9313267.
PMID: 38939745
PMC: 11208798.
DOI: 10.1155/2024/9313267.
Ciclopirox inhibits SARS-CoV-2 replication by promoting the degradation of the nucleocapsid protein.
Wei X, Zhou Y, Shen X, Fan L, Liu D, Gao X
Acta Pharm Sin B. 2024; 14(6):2505-2519.
PMID: 38828154
PMC: 11143514.
DOI: 10.1016/j.apsb.2024.03.009.
A Tiny Viral Protein, SARS-CoV-2-ORF7b: Functional Molecular Mechanisms.
Mansueto G, Fusco G, Colonna G
Biomolecules. 2024; 14(5).
PMID: 38785948
PMC: 11118181.
DOI: 10.3390/biom14050541.
Long way up: rethink diseases in light of phase separation and phase transition.
Ding M, Xu W, Pei G, Li P
Protein Cell. 2023; 15(7):475-492.
PMID: 38069453
PMC: 11214837.
DOI: 10.1093/procel/pwad057.
Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates.
Chen Y, Lei X, Jiang Z, Humphries F, Parsi K, Mustone N
Proc Natl Acad Sci U S A. 2023; 120(47):e2308355120.
PMID: 37963251
PMC: 10666094.
DOI: 10.1073/pnas.2308355120.
Phenotypic Test of Benzo[4,5]imidazo[1,2-c]pyrimidinone-Based Nucleoside and Non-Nucleoside Derivatives against DNA and RNA Viruses, Including Coronaviruses.
Kamzeeva P, Petushkov I, Knizhnik E, Snoeck R, Khodarovich Y, Ryabukhina E
Int J Mol Sci. 2023; 24(19).
PMID: 37834006
PMC: 10572855.
DOI: 10.3390/ijms241914540.
Abnormal phase separation of biomacromolecules in human diseases.
Zhang S, Pei G, Li B, Li P, Lin Y
Acta Biochim Biophys Sin (Shanghai). 2023; 55(7):1133-1152.
PMID: 37475546
PMC: 10423695.
DOI: 10.3724/abbs.2023139.
Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation.
Yi Y, Li W, Liu K, Xue H, Yu R, Zhang M
J Pharm Anal. 2023; .
PMID: 37363744
PMC: 10201890.
DOI: 10.1016/j.jpha.2023.05.011.
Small molecules in regulating protein phase separation.
Li S, Wang Y, Lai L
Acta Biochim Biophys Sin (Shanghai). 2023; 55(7):1075-1083.
PMID: 37294104
PMC: 10415206.
DOI: 10.3724/abbs.2023106.
The preference signature of the SARS-CoV-2 Nucleocapsid NTD for its 5'-genomic RNA elements.
Korn S, Dhamotharan K, Jeffries C, Schlundt A
Nat Commun. 2023; 14(1):3331.
PMID: 37286558
PMC: 10246530.
DOI: 10.1038/s41467-023-38882-y.
Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex.
Cai S, Zhang C, Zhuang Z, Zhang S, Ma L, Yang S
Signal Transduct Target Ther. 2023; 8(1):170.
PMID: 37100798
PMC: 10131525.
DOI: 10.1038/s41392-023-01420-9.
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle.
Di Nunzio F, Uversky V, Mouland A
Retrovirology. 2023; 20(1):4.
PMID: 37029379
PMC: 10081342.
DOI: 10.1186/s12977-023-00619-6.
Phase Separation: The Robust Modulator of Innate Antiviral Signaling and SARS-CoV-2 Infection.
Zheng Y, Gao C
Pathogens. 2023; 12(2).
PMID: 36839515
PMC: 9962166.
DOI: 10.3390/pathogens12020243.
Inhibition of SARS-CoV-2 nucleocapsid protein-RNA interaction by guanosine oligomeric RNA.
Sekine R, Tsuno S, Irokawa H, Sumitomo K, Han T, Sato Y
J Biochem. 2023; 173(6):447-457.
PMID: 36748338
PMC: 11033527.
DOI: 10.1093/jb/mvad008.
Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.
Chau B, Chen V, Cochrane A, Parent L, Mouland A
Cell Rep. 2023; 42(1):111968.
PMID: 36640305
PMC: 9790868.
DOI: 10.1016/j.celrep.2022.111968.
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics.
Wu W, Cheng Y, Zhou H, Sun C, Zhang S
Virol J. 2023; 20(1):6.
PMID: 36627683
PMC: 9831023.
DOI: 10.1186/s12985-023-01968-6.